Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Bronchogenic × Patient Reported Outcome Measures × 30 days × Clear all

Sponsor

Conditions

Preleukemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pathologic Complete Response 1 Neoplasms by Histologic Type 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoproliferative Disorders 1 Lymphoma 1 Lymphatic Diseases 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Leukemia, B-Cell 1 Leukemia 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hematologic Diseases 1 Breast Neoplasms 1 Bone Marrow Diseases 1

Interventions

Carboplatin 3 pembrolizumab 2 durvalumab 2 Pemetrexed 2 Cisplatin 2 pralsetinib 1 ceralasertib 1 Radiosurgery 1 Paclitaxel 1 Gemcitabine 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡